The Conversation
Strengthening Canada's right to repair laws could reduce economic dependence on U.S. imports, boost domestic resilience, and empower consumers and businesses to maintain essential technologies amid rising trade uncertainties.

blg.com
Health Canada's finalized 2025 guidance for machine learning-enabled medical devices introduces a risk-based regulatory framework that emphasizes transparency, bias mitigation, and adaptive oversight, aiming to balance innovation with patient safety.

Gastroenterology & Endoscopy News
Ethylene oxide remains a widely used but controversial sterilization method in healthcare due to its effectiveness for delicate instruments and lack of viable alternatives, despite growing concerns over its toxicity and regulatory pressure to reduce its use.

Yukon News
Issues with the type of water used to clean surgical instruments at one hospital led to 165 surgery cancellations, prompting a shift to reverse osmosis water, external sterilization support, and plans for upgraded equipment and expanded reprocessing capabilities, according to a report.

CPSA
CPSA’s Infection Prevention and Control program supports Alberta medical clinics with evidence-based guidance, resources, and assessments to ensure safe patient care, proper medical device reprocessing, and compliance during clinic construction, renovation, and registration.

National Academy of Medicine
Hospitals can significantly reduce greenhouse gas emissions, cut costs, and strengthen supply chain resilience by expanding regulated reprocessing programs for single-use medical devices.

NetNewsledger.com
Construction has begun on Thunder Bay’s first Cardiovascular Surgery Program, a $93 million initiative that will bring life-saving cardiac procedures to Northwestern Ontario.

McCarthy Tetrault
AI-enabled medical devices are transforming healthcare by improving diagnostics and treatment, but they also challenge existing regulatory frameworks, prompting Health Canada and the FDA to develop risk-based, lifecycle-focused approval pathways that emphasize transparency, bias mitigation, and adaptive oversight through tools like the Predetermined Change Control Plan.

Norton Rose Fulbright
Health Canada’s updated medical device recall regulations now mandate stricter reporting timelines, broaden the definition of “recall” to include government-ordered actions, and exempt low-risk (Type III) recalls from reporting.

Government of Canada
Health Canada is warning consumers about unauthorized blood glucose monitors sold online, which may provide inaccurate readings and pose serious health risks, including potentially life-threatening complications from improper diabetes management.